F. L. Altice

1.1k total citations
16 papers, 770 citations indexed

About

F. L. Altice is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, F. L. Altice has authored 16 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Epidemiology and 4 papers in Virology. Recurrent topics in F. L. Altice's work include HIV/AIDS Research and Interventions (10 papers), HIV, Drug Use, Sexual Risk (8 papers) and HIV Research and Treatment (4 papers). F. L. Altice is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV, Drug Use, Sexual Risk (8 papers) and HIV Research and Treatment (4 papers). F. L. Altice collaborates with scholars based in United States, United Kingdom and Kazakhstan. F. L. Altice's co-authors include Sandra A. Springer, G. Friedland, R. Douglas Bruce, E L Pesanti, Gheorghe Doros, J. L. Hodges, Anne C. Spaulding, Jaimie P. Meyer, Duncan Maru and C. Hardalo and has published in prestigious journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and BMC Infectious Diseases.

In The Last Decade

F. L. Altice

16 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. L. Altice United States 10 527 500 214 206 108 16 770
Lauri Bazerman United States 19 584 1.1× 648 1.3× 228 1.1× 181 0.9× 114 1.1× 38 900
Panagiotis Vagenas United States 14 468 0.9× 488 1.0× 178 0.8× 160 0.8× 146 1.4× 26 686
Andrew Ball Switzerland 13 632 1.2× 428 0.9× 194 0.9× 216 1.0× 80 0.7× 22 859
Marie S. Morgan 8 443 0.8× 664 1.3× 323 1.5× 168 0.8× 142 1.3× 8 860
Andrea Mantsios United States 20 668 1.3× 746 1.5× 171 0.8× 380 1.8× 167 1.5× 35 953
Catalina Ramirez United States 13 295 0.6× 472 0.9× 319 1.5× 149 0.7× 91 0.8× 50 795
Irene Hall United States 9 354 0.7× 505 1.0× 241 1.1× 116 0.6× 127 1.2× 16 637
Ellen W. Wiewel United States 18 488 0.9× 596 1.2× 246 1.1× 212 1.0× 138 1.3× 36 824
Diana M. Sheehan United States 17 461 0.9× 533 1.1× 286 1.3× 205 1.0× 105 1.0× 83 802
Geetha Beauchamp United States 18 567 1.1× 689 1.4× 246 1.1× 160 0.8× 159 1.5× 39 814

Countries citing papers authored by F. L. Altice

Since Specialization
Citations

This map shows the geographic impact of F. L. Altice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. L. Altice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. L. Altice more than expected).

Fields of papers citing papers by F. L. Altice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. L. Altice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. L. Altice. The network helps show where F. L. Altice may publish in the future.

Co-authorship network of co-authors of F. L. Altice

This figure shows the co-authorship network connecting the top 25 collaborators of F. L. Altice. A scholar is included among the top collaborators of F. L. Altice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. L. Altice. F. L. Altice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Cunningham, William E., Robin M. Nance, Carol E. Golin, et al.. (2019). Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations. BMC Infectious Diseases. 19(1). 913–913. 6 indexed citations
3.
Fanfair, Robyn Neblett, Ram K. Shrestha, Liisa M. Randall, et al.. (2019). Implementing Data to Care—What Are the Costs for the Health Department?. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(1). S57–S61. 5 indexed citations
4.
Hughto, Jaclyn M. W., Sari L. Reisner, Trace Kershaw, et al.. (2018). A multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA. Journal of Public Health. 41(1). 100–109. 40 indexed citations
5.
Duerr, Ann, F. L. Altice, Anthony Harries, & Annette H. Sohn. (2012). Antiretroviral Treatment in Resource-Limited Settings 2012. AIDS Research and Treatment. 2012. 1–3. 2 indexed citations
6.
Schackman, Bruce R., Jared A. Leff, Michael Botsko, et al.. (2011). The Cost of Integrated HIV Care and Buprenorphine/Naloxone Treatment: Results of a Cross-Site Evaluation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(Supplement 1). S76–S82. 18 indexed citations
7.
Springer, Sandra A., Anne C. Spaulding, Jaimie P. Meyer, & F. L. Altice. (2011). Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components. Clinical Infectious Diseases. 53(5). 469–479. 134 indexed citations
8.
Altice, F. L., Duncan Maru, R. Douglas Bruce, Sandra A. Springer, & G. Friedland. (2007). Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled Trial. Clinical Infectious Diseases. 45(6). 770–778. 125 indexed citations
9.
Basu, Sanjay, et al.. (2006). Models for Integrating Buprenorphine Therapy into the Primary HIV Care Setting. Clinical Infectious Diseases. 42(5). 716–721. 48 indexed citations
10.
Khalsa, Jag, Frank J. Vocci, F. L. Altice, David A. Fiellin, & Veronica Miller. (2006). Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment. Clinical Infectious Diseases. 43(Supplement 4). S169–S172. 9 indexed citations
11.
Altice, F. L.. (2005). Correlates of HIV Infection Among Incarcerated Women: Implications for Improving Detection of HIV Infection. Journal of Urban Health. 82(2). 312–326. 56 indexed citations
12.
Springer, Sandra A., et al.. (2004). Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners: Reincarceration and the Lack of Sustained Benefit after Release to the Community. Clinical Infectious Diseases. 38(12). 1754–1760. 209 indexed citations
13.
Altice, F. L., Sandra A. Springer, & E L Pesanti. (2004). Reply to Babudieri et al. Clinical Infectious Diseases. 40(2). 322–323. 1 indexed citations
14.
Springer, Sandra A. & F. L. Altice. (2003). Human Immunodeficiency Virus Infection with Human Granulocytic Ehrlichiosis Complicated by Symptomatic Lactic Acidosis. Clinical Infectious Diseases. 36(12). e162–e164. 1 indexed citations
15.
Pollack, Harold A., Kaveh Khoshnood, & F. L. Altice. (1999). Health care delivery strategies for criminal offenders.. PubMed. 26(1). 63–77. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026